《全球慢性阻塞性肺疾病创议》2026关键更新要点解读OA
Key updates and interpretations of the 2026 Global Initiative for Chronic Obstructive Lung Disease(GOLD)Report
慢性阻塞性肺疾病(简称"慢阻肺病")是一种常见的可预防、可治疗的慢性气道疾病,《全球慢性阻塞性肺疾病创议》2026(Global Initiative for Chronic Obstructive Lung Disease 2026,GOLD 2026)的更新围绕早期筛查、动态精准评估,更契合临床实践,并首设人工智能赋能专章,对实现慢阻肺病全生命周期管理提供了指导.笔者现对GOLD 2026的重要更新内容作一解读,旨在更好地理解指南修订的方向和依据,以指导临床实践和未来研究方向.
Chronic obstructive pulmonary disease(COPD)is a common preventable and treatable chronic airway disease.The updated Global Initiative for Chronic Obstructive Lung Disease 2026(GOLD 2026)focuses on early screening and dynamic precise assessment,aligning more closely with clinical practice.For the first time,it includes a dedicated chapter on artificial intelligence empowerment,providing guidance for the implementation of whole-life-cycle management of COPD.The author herein reviews the key updates in GOLD 2026,aiming to facilitate a better understanding of the rationale and direction behind the guideline revisions,thereby informing clinical practice and future research directions.
刘懿典;袁雪芳;龙颖姣
中南大学湘雅二医院呼吸与危重症医学科,长沙 410011湖南旺旺医院呼吸内科,长沙 410009中南大学湘雅二医院呼吸与危重症医学科,长沙 410011||中南大学呼吸疾病研究所,长沙 410011||湖南省呼吸与危重症疾病临床医学研究中心,长沙 410011||中南大学呼吸疾病诊疗中心,长沙 410011
医药卫生
肺疾病,慢性阻塞性评论治疗规范评论
Chronic obstructive pulmonary diseaseReviewTreatmentBenchmarkingComment
《结核与肺部疾病杂志》 2026 (2)
152-155,4
Natural Science Foundation of Hunan Province(2024JJ5487)National Major Scientific and Technological Special Project for Cancer,Cardiovascular and Cerebrovascular,Respiratory,and Metabolic Disease Prevention and Treatment Research(2025ZD0548800)National Key Clinical Specialty Construction Projects of China(Z2023164) 湖南省自然科学基金(2024JJ5487)癌症、心脑血管、呼吸和代谢性疾病防治研究国家科技重大专项(2025ZD0548800)国家临床重点专科建设项目(Z2023164)
评论